Audiovisuell Distraction Via 2d Videoglasses During Catheter Ablation Procedures in Cardiac Rhythm Disorders.
Change of Analgosedation (Remifentanil) Dosage and Increased Patient Satisfaction During Catheter Ablation Procedures in Cardiac Rhythm Disorders Via 2d Audiovisual Distraction.
1 other identifier
interventional
70
1 country
1
Brief Summary
In this randomized controlled trial, amount of sedation exposure and patient satisfaction is evaluated in patients undergoing catheter ablation for rhythm disorders via an audiovisual distraction. Patients are randomized into intervention group (adiovisual distraction) or controll (no intervention).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2019
CompletedFirst Submitted
Initial submission to the registry
January 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2020
CompletedFirst Posted
Study publicly available on registry
May 5, 2021
CompletedMay 5, 2021
April 1, 2021
4 months
January 25, 2020
April 29, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Change of analgosedation dosage
The change of analgosedation dose is measured by comparing the amount of sedation necessary for the procedure in experimental and controll arm. Remifentanyl (Ultiva) is measured in µg/kg/hour Midazolam (Dormicum) is measured in mg/kg/hour
during the procedure (electrophysiological examination on the heart)
Change of stress and anxiety level
The vital parameter blood pressure (in mmHg) serve as surrogate parameter for anxiety and stress.
during the procedure (electrophysiological examination on the heart)
Secondary Outcomes (1)
Patient satisfaction
evaluation before, immediately after and one day after the procedure
Study Arms (2)
Audiovisual distraction using 2d video glasses from HappyMed GmbH
EXPERIMENTALDuring the catheter ablation, the patients in the intervention group receive 2D video glasses with headphones. Immediately before and after the procedure they receive a questionnaire. During the procedure vital parameters of all patients regardless of the studygroup are monitored using "Zoll X-Series Monitor Defibrillator. The study includes blood pressure (in mmHg), heart rate (in beats per minute) and patient's level of alertness, which is assessed using the Richmond Agitation-Sedation Scale(RAAS). During the procedure the patients in the intervention group receive the glasses and remote control. All patients receive their individual dosage to ensure painless ablation. The drugs used are limited to the opioids remifentanil and benzodiazepine midazolam.
Controll arm
NO INTERVENTIONIn patients in the control group, catheter ablation is performed as usual without the use of video glasses. They receive immediately before and after the ablation the same questionnaire as the patients in experimental arm. (Omitting the question about the videoglasses). While the procedure is performed, the analgosediation is as well in the controll arm as in the experimental arm titrated until the patient is treated, sedated and painless.
Interventions
Patients receive optical and acustical relaxing material during the procedure by using 2d video glasses from HappyMed GmbH
Eligibility Criteria
You may qualify if:
- Patient undergoing catheter ablation for rhythm disorders
You may not qualify if:
- epilepsy
- age \<18 years
- visus \<-5 dpt or \>+2 dpt
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Essen
Essen, North Rhine-Westphalia, 45147, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2020
First Posted
May 5, 2021
Study Start
November 20, 2019
Primary Completion
March 13, 2020
Study Completion
March 14, 2020
Last Updated
May 5, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share